S&P 500   3,205.38 (-0.66%)
DOW   26,772.64 (-0.36%)
S&P 500   3,205.38 (-0.66%)
DOW   26,772.64 (-0.36%)
S&P 500   3,205.38 (-0.66%)
DOW   26,772.64 (-0.36%)
S&P 500   3,205.38 (-0.66%)
DOW   26,772.64 (-0.36%)
Log in

NYSE:SYKStryker Stock Price, Forecast & News

$186.23
-2.40 (-1.27 %)
(As of 07/16/2020 11:30 AM ET)
Add
Compare
Today's Range
$185.46
Now: $186.23
$187.27
50-Day Range
$173.76
MA: $187.92
$207.03
52-Week Range
$124.54
Now: $186.23
$226.30
Volume379,005 shs
Average Volume1.62 million shs
Market Capitalization$69.80 billion
P/E Ratio32.73
Dividend Yield1.26%
Beta0.84
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More
Stryker logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.26 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$10.67 per share
Book Value$34.23 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Employees40,000
Market Cap$69.80 billion
Next Earnings Date7/30/2020 (Confirmed)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 6.0% and is now trading at $186.23. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Stryker?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Stryker.

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its earnings results on Thursday, April, 30th. The medical technology company reported $1.84 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.15. The medical technology company earned $3.59 billion during the quarter, compared to analysts' expectations of $3.45 billion. Stryker had a net margin of 14.47% and a return on equity of 24.90%. The company's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.88 EPS. View Stryker's earnings history.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.575 per share on Friday, July 31st. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Monday, June 29th. View Stryker's dividend history.

What price target have analysts set for SYK?

27 equities research analysts have issued 1-year target prices for Stryker's shares. Their forecasts range from $150.00 to $248.00. On average, they anticipate Stryker's share price to reach $215.20 in the next twelve months. This suggests a possible upside of 15.6% from the stock's current price. View analysts' price targets for Stryker.

Has Stryker been receiving favorable news coverage?

Media coverage about SYK stock has been trending positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stryker earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned press coverage about the medical technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View the latest news about Stryker.

Are investors shorting Stryker?

Stryker saw a drop in short interest in June. As of June 15th, there was short interest totaling 3,130,000 shares, a drop of 24.0% from the May 31st total of 4,120,000 shares. Based on an average daily volume of 2,390,000 shares, the short-interest ratio is presently 1.3 days. Approximately 0.9% of the shares of the company are short sold. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Medtronic (MDT), Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Visa (V), Alibaba Group (BABA), Bank of America (BAC) and NVIDIA (NVDA).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Welch & Forbes LLC (0.14%), LGT Capital Partners LTD. (0.10%), Confluence Investment Management LLC (0.09%), Envestnet Asset Management Inc. (0.08%), Whittier Trust Co. (0.05%) and Chesley Taft & Associates LLC (0.04%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, Dalton Greiner Hartman Maher & Co., Central Bank & Trust Co., McGuire Investment Group LLC, Exchange Traded Concepts LLC, TIAA FSB, Private Trust Co. NA, and Addenda Capital Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

Which institutional investors are buying Stryker stock?

SYK stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Park National Corp OH, American National Bank, LGT Capital Partners LTD., Carnegie Capital Asset Management LLC, Canandaigua National Corp, Legacy Private Trust Co., and Fulton Bank N. A.. View insider buying and selling activity for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $186.23.

How big of a company is Stryker?

Stryker has a market capitalization of $69.80 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.